Biological Industries Expands to the United States, Providing Innovative Research Technology to the U.S. Life Sciences Market

CROMWELL, Conn. & KIBBUTZ BEIT HAEMEK, Israel

Biological Industries (“BI”; www.bioind.com), a leading developer and manufacturer of cell culture media, molecular biology tools, human cytogenetics media, and custom media manufacturing services, announced today that it is expanding its operations into the United States. The company, which prides itself on over 30 years of cell culture media development expertise, state-of-the-art cGMP facilities, and key partnerships with some of the world’s leading scientists, will launch Biological Industries USA, Inc. (“BI-USA”) to market and distribute its products in the United States.

“This expansion is part of Biological Industries’ planned growth strategy and provides geographic support for scientists in the United States region,” says CEO Alon Ariel. “Previously, BI has partnered with strategic distributors within the US in order to market our technology. With BI-USA, not only will our product portfolio be easily and directly available to US researchers, but they will now have direct access to our scientists and internal technical expertise as well.”

BI-USA will focus on high-growth, establishing cell culture training programs, and expanding collaborations within the stem cell and conventional cell culture fields.

Moshe Kapelnikov, newly appointed BI-USA CEO says, “We are excited to bring BI’s strong momentum and expertise in the cell culture field to the US. Our strategic partners have helped market some of our flagship products, including the NutriStem® family of xeno-free, serum-free stem cell culture reagents, optimized karyotyping media, and classical tissue culture media, providing us with a great platform in the US to work with.

The organization is working towards launching the BI-USA brand and developing a new, fully integrated global website, set to launch this fall. Customers can begin ordering products directly through BI-USA beginning November 1, 2015. Please contact Customer Service at 860-316-2702 or email orders-usa@bioind.com. BI-USA will be located on the East Coast in Cromwell, Connecticut. To learn more about the company’s expansion, please visit at www.bioind.com.

About Biological Industries

BIOLOGICAL INDUSTRIES (BI) develops, manufactures, and supplies life science products to universities, government research, healthcare institutions, and the biopharmaceutical industry. For over 30 years, BI has been working alongside some of the world’s leading academic researchers and institutes in the development of cell culture media, stem cell reagents, and molecular biology tools. BI also offers custom media development and manufacturing services through its ISO 13485:2003 certified cGMP facilities. BI currently supplies products to researchers and clinicians in over 40 countries with products currently in clinical trials. BI is leveraging their industry-leading experience in cell culture media and pluripotent stem cell technology to help facilitate breakthroughs in stem cell research worldwide. BI is committed to a Culture of Excellence by providing the highest quality reagents and cost-effective, innovative products and services tailored to a customer’s specific needs.

To receive ongoing BI communications, please join our email list or connect with the company on LinkedIn, Twitter, and Facebook.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151027006365/en/

Media:
Biological Industries USA, Inc.
Moshe Kapelnikov
CEO
moshe@bioind.com
or
Biological Industries USA, Inc.
Tanya Potcova, 860-670-5407
Marketing Director
tanya@bioind.com
or
Media:
Gotham Communications, LLC
Bill Douglass, 646-504-0890
bill@gothamcomm.com